4
Changes in Ownership
Aquestive Therapeutics, Inc. Filed Acc 0001140361-18-044950
Chief Innovation/Tech Officer bought 1,000 shares at $7.78 ($7,780)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schobel Alexander Mark Chief Innovation/Tech Officer | 2018-12-10 | Purchase | +1,000 | $7.78 | $7,780 | 1,019,624 | D |
| Open-market purchases · 1,000 sh · avg $7.78 · $7,780 | |||||||
Loading xslF345X03/form4.xml…